Literature DB >> 21868359

A polymorphism-specific "memory" mechanism in the β(2)-adrenergic receptor.

Andrea Ahles1, Francesca Rochais, Torsten Frambach, Moritz Bünemann, Stefan Engelhardt.   

Abstract

Signaling through G protein (heterotrimeric guanosine triphosphate-binding protein)-coupled receptors is affected by polymorphisms in receptor-encoding genes. Using fluorescence resonance energy transfer, we found that the β(2)-adrenergic receptor (β(2)AR) responded to repeated activation with altered activation kinetics. Polymorphic variants of the β(2)AR displayed divergent changes of β(2)AR activation kinetics that closely mimicked their different efficacies to generate cyclic adenosine 3',5'-monophosphate. More efficacious variants became faster in their activation kinetics, whereas less efficacious variants became slower, compared to their initial activation. These differences depended on phosphorylation of the receptor by G protein-coupled receptor kinases. Our findings suggest an intrinsic, polymorphism-specific property of the β(2)AR that alters activation kinetics upon continued stimulation and that may account for individual drug responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21868359     DOI: 10.1126/scisignal.2001681

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  10 in total

Review 1.  Optical probes based on G protein-coupled receptors - added work or added value?

Authors:  A D Stumpf; C Hoffmann
Journal:  Br J Pharmacol       Date:  2015-12-19       Impact factor: 8.739

2.  Interhelical interaction and receptor phosphorylation regulate the activation kinetics of different human β1-adrenoceptor variants.

Authors:  Andrea Ahles; Fabian Rodewald; Francesca Rochais; Moritz Bünemann; Stefan Engelhardt
Journal:  J Biol Chem       Date:  2014-12-01       Impact factor: 5.157

3.  Beta-adrenergic receptors gene polymorphisms are associated with cardiac contractility and blood pressure variability.

Authors:  L Matuskova; B Czippelova; Z Turianikova; D Svec; Z Kolkova; Z Lasabova; M Javorka
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

4.  The Val34Met, Thr164Ile and Ser220Cys Polymorphisms of the β2-Adrenergic Receptor and Their Consequences on the Receptor Conformational Features: A Molecular Dynamics Simulation Study.

Authors:  Aneta Archala; Wojciech Plazinski; Anita Plazinska
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

5.  Medication Rules in Herbal Medicine for Mild Cognitive Impairment: A Network Pharmacology and Data Mining Study.

Authors:  Z Chang; Yu-Chun Wang; Danfeng Tian; Wen-Yue Hu; Zhen-Yi Wang; Gan-Lu Liu; Hua-Ping Ma; Yu-Li Hu; Bin Wu; Zhen-Yun Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-18       Impact factor: 2.650

6.  Increased agonist affinity at the μ-opioid receptor induced by prolonged agonist exposure.

Authors:  William T Birdsong; Seksiri Arttamangkul; Mary J Clark; Kejun Cheng; Kenner C Rice; John R Traynor; John T Williams
Journal:  J Neurosci       Date:  2013-02-27       Impact factor: 6.167

7.  Differential Dynamics Underlying the Gln27Glu Population Variant of the β2-Adrenergic Receptor.

Authors:  Sumedha Bhosale; Siddhanta V Nikte; Durba Sengupta; Manali Joshi
Journal:  J Membr Biol       Date:  2019-09-13       Impact factor: 1.843

Review 8.  Molecular signatures of G-protein-coupled receptors.

Authors:  A J Venkatakrishnan; Xavier Deupi; Guillaume Lebon; Christopher G Tate; Gebhard F Schertler; M Madan Babu
Journal:  Nature       Date:  2013-02-14       Impact factor: 49.962

9.  Molecular insights into the dynamics of pharmacogenetically important N-terminal variants of the human β2-adrenergic receptor.

Authors:  Ganesh Shahane; Chirag Parsania; Durba Sengupta; Manali Joshi
Journal:  PLoS Comput Biol       Date:  2014-12-11       Impact factor: 4.475

10.  Altered sympathetic-to-immune cell signaling via β₂-adrenergic receptors in adjuvant arthritis.

Authors:  Dianne Lorton; Denise L Bellinger; Jill A Schaller; Eric Shewmaker; Tracy Osredkar; Cheri Lubahn
Journal:  Clin Dev Immunol       Date:  2013-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.